Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more) Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more) Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spectral Medical Inc EDTXF


Primary Symbol: T.EDT

Healthcare Biotechnology Medical Instruments & Supplies
Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

Recent & Breaking News (TSX:EDT)

Largest Japanese Registry Data Analysis Demonstrates Significant Reduction in Mortality Rate of Septic Patients Treated With Toraymyxin(TM)

Marketwired November 25, 2014

Spectral Announces Third Quarter 2014 Results

Marketwired November 13, 2014

Spectral (T.SDI) expects commercialization of septic shock treatment as early as H1 2016

Stockhouse Editorial November 5, 2014

Spectral Provides Update on Its Path to Commercialization

Marketwired November 5, 2014

Spectral to Exhibit at the Critical Care Canada Forum

Canada NewsWire October 29, 2014

Spectral announces board changes

Canada NewsWire September 24, 2014

Spectral Announces Second Quarter, 2014 Results

Canada NewsWire August 13, 2014

Spectral Diagnostics and Toray Industries announce closing of Tranche "A" component of its up to $18.2 million Offering

Canada NewsWire July 25, 2014

Spectral Diagnostics announces shareholder approval of its up to $18.2 million offering

Canada NewsWire July 22, 2014

Spectral Announces ISS and Glass Lewis Recommendations to Vote in Favour of its up to $18.2 Million Offering

Canada NewsWire July 8, 2014

Spectral Diagnostics announces Proposed Offering of up to $18.2 million

Canada NewsWire June 11, 2014

U.S. FDA Approves Spectral's Amended Protocol for its EUPHRATES Trial

Canada NewsWire June 3, 2014

Spectral announces first quarter, 2014 results

Canada NewsWire May 15, 2014

Spectral Diagnostics provides update on results of annual and special meeting of shareholders

Canada NewsWire May 6, 2014

Spectral Diagnostics Announces Leading Independent Proxy Firms Recommend Spectral Shareholders Vote For Name Change and For Amendment of Warrants

Canada NewsWire April 21, 2014

Spectral Diagnostics (T.SDI) jumps 24% on EUPHRATES trial update

Gaalen Engen April 14, 2014

Spectral Updates Status Of EUPHRATES Trial

Canada NewsWire April 14, 2014

Spectral announces fourth quarter and fiscal 2013 results

Canada NewsWire March 27, 2014

Spectral Diagnostics Provides Clinical Update on the Euphrates Trial

Canada NewsWire March 11, 2014

Spectral Diagnostics Announces Extension of Warrants

Canada NewsWire February 24, 2014